Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 1
1979 4
1980 5
1981 4
1982 1
1983 2
1984 7
1985 3
1986 8
1987 6
1988 11
1989 10
1990 4
1991 6
1992 9
1993 3
1994 14
1995 12
1996 15
1997 13
1998 15
1999 11
2000 16
2001 16
2002 14
2003 27
2004 23
2005 31
2006 30
2007 38
2008 44
2009 29
2010 51
2011 66
2012 56
2013 65
2014 71
2015 81
2016 110
2017 102
2018 101
2019 95
2020 63
Text availability
Article attribute
Article type
Publication date

Search Results

1,161 results
Results by year
Filters applied: . Clear all
Page 1
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
Marwick TH, Ritchie R, Shaw JE, Kaye D. Marwick TH, et al. J Am Coll Cardiol. 2018 Jan 23;71(3):339-351. doi: 10.1016/j.jacc.2017.11.019. J Am Coll Cardiol. 2018. PMID: 29348027 Free article. Review.
Heart failure is a complex clinical syndrome, the incidence and prevalence of which is increased in diabetes mellitus, pre-diabetes, and obesity. ...Despite epidemiological evidence linking diabetes to heart failure incidence and outcome, the presence …
Heart failure is a complex clinical syndrome, the incidence and prevalence of which is increased in diabetes mellitus, pre- …
Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments.
Iwakura K. Iwakura K. J Echocardiogr. 2019 Dec;17(4):177-186. doi: 10.1007/s12574-019-00446-9. Epub 2019 Oct 15. J Echocardiogr. 2019. PMID: 31617144 Review.
Heart failure is one of the major cardiovascular complications in patients with type 2 diabetes mellitus (T2DM) and increases the risk of morbidity and mortality. ...Left ventricular hypertrophy, left atrial dilatation, diastolic dysfunction, and subclinical systoli …
Heart failure is one of the major cardiovascular complications in patients with type 2 diabetes mellitus (T2DM) and increases …
Diabetic cardiomyopathy: pathophysiology and clinical features.
Miki T, Yuda S, Kouzu H, Miura T. Miki T, et al. Heart Fail Rev. 2013 Mar;18(2):149-66. doi: 10.1007/s10741-012-9313-3. Heart Fail Rev. 2013. PMID: 22453289 Free PMC article. Review.
Circumstantial evidence to date indicates that diabetic cardiomyopathy is a common but frequently unrecognized pathological process in asymptomatic diabetic patients. ...Here, we review both basic and clinical studies on diabetic cardiomyopathy
Circumstantial evidence to date indicates that diabetic cardiomyopathy is a common but frequently unrecognized pathological pr …
Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
Xue M, Li T, Wang Y, Chang Y, Cheng Y, Lu Y, Liu X, Xu L, Li X, Yu X, Sun B, Chen L. Xue M, et al. Clin Sci (Lond). 2019 Aug 2;133(15):1705-1720. doi: 10.1042/CS20190585. Print 2019 Aug 15. Clin Sci (Lond). 2019. PMID: 31337673
Cardiovascular complications contribute to the major mortality and morbidity in type 2 diabetes. Diabetic cardiomyopathy (DCM) is increasingly recognized as an important cause of heart failure. ...Echocardiography revealed that both systolic and diasto …
Cardiovascular complications contribute to the major mortality and morbidity in type 2 diabetes. Diabetic cardiomyopathy
Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus.
Langhorn R, Kieler IN, Koch J, Christiansen LB, Jessen LR. Langhorn R, et al. J Vet Intern Med. 2018 Jan;32(1):57-63. doi: 10.1111/jvim.14902. Epub 2017 Dec 12. J Vet Intern Med. 2018. PMID: 29230874 Free PMC article.
HYPOTHESIS: Hypertrophic cardiomyopathy (HCM) and diabetes mellitus (DM), independently of CKD, are associated with changes in serum SDMA. ...Clinical examination, echocardiography, ECG, blood pressure, CBC, biochemistry, thyroxine, and SDMA measuremen …
HYPOTHESIS: Hypertrophic cardiomyopathy (HCM) and diabetes mellitus (DM), independently of CKD, are associated with cha …
Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure.
Swoboda PP, McDiarmid AK, Erhayiem B, Ripley DP, Dobson LE, Garg P, Musa TA, Witte KK, Kearney MT, Barth JH, Ajjan R, Greenwood JP, Plein S. Swoboda PP, et al. J Am Heart Assoc. 2017 Jul 17;6(7):e005539. doi: 10.1161/JAHA.117.005539. J Am Heart Assoc. 2017. PMID: 28716801 Free PMC article. Clinical Trial.
METHODS AND RESULTS: In a case-controlled observational study 130 subjects including 50 ACR+ve diabetes mellitus patients with persistent microalbuminuria (ACR >2.5 mg/mol in males and >3.5 mg/mol in females, ≥2 measurements, no previous renin-angiotensin-aldo …
METHODS AND RESULTS: In a case-controlled observational study 130 subjects including 50 ACR+ve diabetes mellitus patients with …
Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis.
Yao Q, Ke ZQ, Guo S, Yang XS, Zhang FX, Liu XF, Chen X, Chen HG, Ke HY, Liu C. Yao Q, et al. J Mol Cell Cardiol. 2018 Nov;124:26-34. doi: 10.1016/j.yjmcc.2018.10.004. Epub 2018 Oct 4. J Mol Cell Cardiol. 2018. PMID: 30292723
Our study suggests that curcumin protects against diabetic cardiomyopathy by modulating the crosstalk between autophagic and apoptotic machinery. Modulation of autophagy may be an effective strategy for the treatment of cardiovascular diseases associated with dia
Our study suggests that curcumin protects against diabetic cardiomyopathy by modulating the crosstalk between autophagic and a …
NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B, Li B, Wang W, Liu X, Xia Y, Zhang C, Zhang M, Zhang Y, An F. Luo B, et al. PLoS One. 2014 Aug 19;9(8):e104771. doi: 10.1371/journal.pone.0104771. eCollection 2014. PLoS One. 2014. PMID: 25136835 Free PMC article.
BACKGROUND: Nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome is associated with metabolic disorder and cell death, which are important triggers in diabetic cardiomyopathy (DCM). ...METHODS: Type 2 diabetic rat model was i …
BACKGROUND: Nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome is associated with metabolic disorder and …
miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes.
Feng B, Chen S, Gordon AD, Chakrabarti S. Feng B, et al. J Mol Cell Cardiol. 2017 Apr;105:70-76. doi: 10.1016/j.yjmcc.2017.03.002. Epub 2017 Mar 6. J Mol Cell Cardiol. 2017. PMID: 28279663
Hyperglycemia induced endothelial injury is a key pathogenetic factor in diabetic cardiomyopathy. In diabetes, changes in pro-inflammatory cytokines are a key mechanism leading to cardiac fibrosis. ...We examined these mice and wild type littermate controls w …
Hyperglycemia induced endothelial injury is a key pathogenetic factor in diabetic cardiomyopathy. In diabetes, changes …
Tissue-engineered smooth muscle cell and endothelial progenitor cell bi-level cell sheets prevent progression of cardiac dysfunction, microvascular dysfunction, and interstitial fibrosis in a rodent model of type 1 diabetes-induced cardiomyopathy.
Kawamura M, Paulsen MJ, Goldstone AB, Shudo Y, Wang H, Steele AN, Stapleton LM, Edwards BB, Eskandari A, Truong VN, Jaatinen KJ, Ingason AB, Miyagawa S, Sawa Y, Woo YJ. Kawamura M, et al. Cardiovasc Diabetol. 2017 Nov 2;16(1):142. doi: 10.1186/s12933-017-0625-4. Cardiovasc Diabetol. 2017. PMID: 29096622 Free PMC article.
BACKGROUND: Diabetes mellitus is a risk factor for coronary artery disease and diabetic cardiomyopathy, and adversely impacts outcomes following coronary artery bypass grafting. Current treatments focus on macro-revascularization and neglect the microv …
BACKGROUND: Diabetes mellitus is a risk factor for coronary artery disease and diabetic cardiomyopathy, and adve …
1,161 results
Jump to page
Feedback